Condition: Glioma · Glioneuronal Tumor · Choroid Plexus Tumor · Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO classification, based on cIMPACT-NOW recommendations, results in more homogeneous patient groups than the old 2016 classification. Furthermore, it will help derive provisional guidelines on how patients with these newly defined tumour entities are best treated. These recommendations will be based on the experience of EORTC investigators with chosen treatments and their experience as reported in this data collection report.
This description comes directly from the study's public registry record.
EORTC HQ · +32 2 774 1611 · eortc@eortc.org
Always discuss trial participation with your own doctor first.
| Innsbruck Universitaetsklinik | Innsbruck, Austria | Recruiting |
| Universitaetsklinikum Wien - AKH unikliniken | Vienna, Austria | Recruiting |
| Onze Lieve Vrouw Ziekenhuis | Aalst, Belgium | Recruiting |
| Institut Jules Bordet | Anderlecht, Belgium | Recruiting |
| Universitair Ziekenhuis Brussel | Brussels, Belgium | Recruiting |
| C.H.U. Sart-Tilman | Liège, Belgium | Recruiting |
| AZ Delta - Campus Rumbeke | Roeselare, Belgium | Recruiting |
| CHU Lyon - Hopital neurologique Pierre Wertheimer | Lyon, France | Recruiting |
| Hopital de La Timone | Marseille, France | Recruiting |
| Hopital la Pitie-Salpetriere | Paris, France | Recruiting |
| Knappschaft Krankenhaus Langendreer | Bochum, Germany | Recruiting |
| Universitaetsklinikum Bonn | Bonn, Germany | Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05259605